April 24, 2026 BPC-157 delivery routes research covering subcutaneous, intramuscular, oral, and other administration routes, pharmacokinetic profiles, and tissue distribution in animal research models
Patients should avoid self-sourcing or using it without clinical guidance
Health Canada noted that a causal link had not been established between the products and the reported adverse effects
Suprascapular block (in the shoulder): Relieves pain in the shoulder area from degenerative disease or arthritis
Most patients experience symptomatic improvement within 1-2 weeks, with objective measures improving over 4-8 weeks
At clinical doses under supervision, the most common side effects are mild nausea in the first week (typically resolves by day 7 to 10), injection site reactions (redness, minor swelling, localized soreness lasting 24 hours), and occasional transient fatigue or mild headache in the first few days